Trial NCT04899232

View at ClinicalTrials.gov 
Org. Study IDs: 20201048

Last trial update was posted on 2022-09-07

MeSH Interventions

Antithrombin III Antithrombins

MeSH Conditions

Antithrombin III Deficiency COVID-19 Communicable Diseases Infections

Other Conditions

Covid19

Stopping Reasons

There are fewer potential patients and an early conclusion of the study would be beneficial in an attempt to finish in a reasonable time and keep the cohorts homogenous.

Limitations And Caveats

With decreased Coronavirus disease of 2019 (COVID-19) cases, enrollment slowed leading to the early termination of the trial; the target number of 75 enrolled patients was not reached. Hesitancy to participate in the trial was noted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID